realtrafficexchange

Technorati

Technorati Profile

Bextra Information

Bextra, a cox-2 inhibitor drug manufactured by pharmaceutical giant Pfizer, was approved for use in the United States in November 2001. It is alleged that at the time of approval, the FDA were aware of some serious skin-related side effects that could occur from using the drug. Nevertheless, approval was given and the drug was welcomed by medics and patients all over the country. Along with other cox-2 inhibitors, such as Vioxx, Bextra was able to isolate the cox-2 enzyme produced by the body and could therefore provide the benefits of a traditional non-steroid anti-inflammatory drug without the gastric discomfort that came with most.
The recent withdrawal of another cox-2 inhibitor, Vioxx, has created a wave of concern about the dangers of Bextra and other cox-2s. Vioxx, which was manufactured and voluntarily recalled by manufacturing giant, Merck, was found to result in a dramatically increased risk of heart attacks and strokes in patients. There are no concerns – and allegedly some preliminary evidence – to show that Bextra may be linked to these deadly side effects in the same way as Vioxx.